Supervised for Endoscopy (procedure)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Endoscopy (procedure)
Supervision/Coaching - Behavioral
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether it is better for medical students to learn how to do a colonoscopy by practicing on a simulator twice with no supervision and then being supervised while doing it twice, or the reverse.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Endoscopy (procedure)

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: through study completion, an average of 1 year

Year 1
Participant satisfaction score
Percentage of mucosa inspected
Time to reach cecum

Trial Safety

Safety Progress

1 of 3

Other trials for Endoscopy (procedure)

Trial Design

2 Treatment Groups

Supervised
1 of 2
Unsupervised
1 of 2
Active Control

50 Total Participants · 2 Treatment Groups

Primary Treatment: Supervised · No Placebo Group · N/A

Supervised
Behavioral
ActiveComparator Group · 1 Intervention: Supervision/Coaching · Intervention Types: Behavioral
Unsupervised
Behavioral
ActiveComparator Group · 1 Intervention: Supervision/Coaching · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year

Who is running the clinical trial?

University of OklahomaLead Sponsor
419 Previous Clinical Trials
97,020 Total Patients Enrolled
William Tierney, MDPrincipal InvestigatorUniversity of Oklahoma
3 Previous Clinical Trials
1,105 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 31st, 2021

Last Reviewed: October 16th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.